Beam Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) Transcript

Jan 12, 2021 / 04:40PM GMT
Eric William Joseph - JPMorgan Chase & Co, Research Division - VP & Senior Analyst

All right. Thanks again for joining us at our health care conference. I'm Eric Joseph, senior biotech analyst at JPMorgan. And our next presenting company is Beam Therapeutics. And it's my pleasure to welcome John Evans, CEO, to tell us a little bit about the company. Before I hand it over for the presentation, I just want to note that there is a Q&A after the presentation. (Operator Instructions)

With that, John, thanks again for joining us today.

John M. Evans - Beam Therapeutics Inc. - CEO & Director

All right. Thank you, Eric. Hello, everybody. Great to be here today. Sorry, not to be in-person San Francisco, but nonetheless excited to be entering the new year, 2021. Okay. So I'm going to walk you through a little bit about Beam today. I'll be referring to the slides, which I know you have access to as well. And Beam is really trying to create a new class of precision genetic medicines using base editing, and I'm going to tell you about that technology

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot